Our research, development, and production focus on high-end medical devices (such as fluorescence imaging series), fluorescence contrast agent drugs (such as ICG, targeted contrast agent series, etc.), and core components (such as fluorescence CMOS camera modules, endoscopes, etc.), providing full-chain solutions. These products have been utilized in more than 500 large hospitals.

We focus on core technologies such as molecular fluorescence, Raman spectroscopy, AI, computer-aided drug molecular design (CADD), and AI-assisted drug design. As a specialized and sophisticated enterprise, we have undertaken numerous national and provincial key research projects. We hold 131 core invention patents and 7 US invention patents.

As a strategic partner of international leading medical companies in Germany and Japan, we have established cooperative businesses with more than 10 overseas countries.